At ACRI, maintaining the highest biosafety standards is essential to ensuring a safe, compliant research environment for all staff, trainees, and collaborators. Our Research Biosafety Program provides guidance, oversight, and support for research involving biological materials, including recombinant or synthetic nucleic acids, infectious agents, and other biohazardous materials. We are committed to promoting a culture of safety, regulatory compliance, and responsible research practices.

Questions about Research Biosafety?

If you need additional information or have questions regarding Research Biosafety at ACRI, please contact the Research Biosafety Specialist and the Research Biosafety Committee, ResearchBioSafetyCommittee@archildrens.org.

As part of our commitment to transparency and compliance with federal guidelines, ACRI has implemented procedures to ensure public access to Institutional Biosafety Committee (IBC) meeting minutes. In accordance with recent NIH guidance, external IBC administered for ACRI will publicly post approved minutes for IBC meetings occurring on or after June 1, 2025.  These minutes will be made available immediately following approval and after all appropriate and allowable redactions have been completed.

ACRI utilizes external administered Institutional Biosafety Committee (IBC). Please use the links below to access IBC meeting minutes as they pertain to ACRI: